99 related articles for article (PubMed ID: 53983)
41. [Effect of cytostatic drugs and hydrocortisone on healing of surgical wounds inoculated with Ehrlich's cancer].
Romatowski J; Kubicki B
Pol Tyg Lek; 1967 Dec; 22(51):1971-3. PubMed ID: 5584359
[No Abstract] [Full Text] [Related]
42. Special ultrastructural features of parathyroid cells from Swiss mice bearing Ehrlich's ascites tumor.
Latta JS; Rutz TJ
Anat Rec; 1968 Feb; 160(2):255-9. PubMed ID: 5651672
[No Abstract] [Full Text] [Related]
43. [An experimental model of metastatic liver involvement by using Ehrlich's ascitic cancer].
Udintsev SN; Fomina TI; Razina TG
Vopr Onkol; 1992; 38(6):723-6. PubMed ID: 1300773
[No Abstract] [Full Text] [Related]
44. [Fluorescent cytochemical study of the effect of gamma rays and radiotoxins on Ehrlich's ascitic carcinoma cells].
Kondratenko VG; Khakimov PA
Radiobiologiia; 1968; 8(3):418-24. PubMed ID: 5754606
[No Abstract] [Full Text] [Related]
45. [Determination of cytotoxic properties of the blood serum by the acid phosphatase reaction in the ascitic cells of Ehrlich's carcinoma].
Dimenshteĭn IB; Nemirova PE
Lab Delo; 1973; 2():101-3. PubMed ID: 4131737
[No Abstract] [Full Text] [Related]
46. [Antitumor activity of doxorubicin in the treatment of hemocytoblastosis La and various ascites tumors in mice].
Ul'ianova LA; Tarasova VE; Bazhanov VS; Iudina OI; Gol'dberg LE
Antibiotiki; 1984 Nov; 29(11):861-6. PubMed ID: 6524889
[TBL] [Abstract][Full Text] [Related]
47. The metabolism of calcium and phosphorus and the cellular lipoproteins of the Ehrlich's ascites tumor cell.
Anghileri LJ
Int J Clin Pharmacol; 1974 Jul; 10(1):23-9. PubMed ID: 4854956
[No Abstract] [Full Text] [Related]
48. [The graft of Ehrlich's adenocarcinoma in the normal and hypertrophic kidney (author's transl)].
Michelazzi A; Burlando F
Pathologica; 1979; 71(1012):195-9. PubMed ID: 471541
[No Abstract] [Full Text] [Related]
49. [Effect of carminomycin on the structural integrity, primary susceptibility to radiation damage and the postradiation repair of the cellular DNA-membrane complex in Ehrlich's ascitic carcinoma].
Paranosenkova VI; Saenko AS
Antibiotiki; 1981 Apr; 26(4):306-10. PubMed ID: 7235672
[TBL] [Abstract][Full Text] [Related]
50. [Temporal organization of the cellular reproduction processes in Ehrlich ascites tumor].
Romanov IuA; Stepanenko VA
Biull Eksp Biol Med; 1985 Aug; 100(8):228-9. PubMed ID: 4027372
[TBL] [Abstract][Full Text] [Related]
51. [Effect of methotrexate on growth kinetics in Ehrlich's carcinoma].
Czerniak B; Mietkiewski J; Mazuryk R
Patol Pol; 1976; 27(3):219-30. PubMed ID: 967534
[No Abstract] [Full Text] [Related]
52. Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich's carcinoma grown in mice: role of thioredoxin-interacting protein.
Ali BM; Zaitone SA; Shouman SA; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2015 Dec; 388(12):1271-82. PubMed ID: 26264806
[TBL] [Abstract][Full Text] [Related]
53. [Effect of a Rhodiola extract on the tumor process in an experiment].
Dement'eva LA; Iaremenko KV
Vopr Onkol; 1987; 33(7):57-60. PubMed ID: 3617612
[TBL] [Abstract][Full Text] [Related]
54. Protective effect of fungal growth product (6MFA), assessed therapeutically against Ehrlich's ascites tumor in Swiss mice.
Mall SA; Zaidi SI; Hussain MM; Singh KP; Mathur N; Gupta BM
J Biol Regul Homeost Agents; 1991; 5(2):45-51. PubMed ID: 1897382
[TBL] [Abstract][Full Text] [Related]
55. [Effects of P32 in ionic form on the cells of Ehrlich's ascites tumor].
Piccotti F; Cirillo R; Ferrero B; Ballaira L
Cancro; 1967; 20(3):303-22. PubMed ID: 5605377
[No Abstract] [Full Text] [Related]
56. Characterization of the antitumor activity of a polyantigenic immunomodulator (PAI): II--Involvement of NK cells and adoptive immunotherapy.
Orraca ZM; Ríos-Olivares E; Carrasco-Canales JA; Aquino E; Marchand AM; Colón JI
Bol Asoc Med P R; 1989 Jul; 81(7):254-8. PubMed ID: 2775402
[TBL] [Abstract][Full Text] [Related]
57. [Action of the chalone from Ehrlich's ascites, tumor in mice on the mitotic activity in this tumor after single and double administrations].
Romanov IuA; Semenova MV
Biull Eksp Biol Med; 1980 Feb; 89(2):189-91. PubMed ID: 6445214
[TBL] [Abstract][Full Text] [Related]
58. [Mechanism of various degrees of tumor sensitivity to olivomycin].
Reztsova VV
Antibiotiki; 1981 May; 26(5):391-3. PubMed ID: 7259149
[TBL] [Abstract][Full Text] [Related]
59. [Cellular transport mechanisms for 57Co-bleomycin].
Metelmann HR; Bier J; Bitter K
Dtsch Zahnarztl Z; 1980 Jan; 35(1):99-101. PubMed ID: 6157514
[TBL] [Abstract][Full Text] [Related]
60. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
D'Alessandro G; Giammanco G; Barncato P
Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
